Navigation Links
Waters Introduces New TruView LCMS Certified Vials for the Analytical Laboratory
Date:9/29/2011

MILFORD, Mass., Sept. 29, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced TruView™ LCMS Certified Vials, a new line of low-adsorption sample vials certified for LC/MS/MS analyses where analyte concentrations are on the order of ng/mL or pg/mL and where analytical sensitivity and accuracy are critical.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

"As LC/MS/MS technology evolves and levels of detection approach or exceed the part-per-trillion range, our customers are demanding low adsorption vials that won't compromise their results," said Mike Yelle, Senior Director, Chemistry Commercial Operations, Waters Division. "Our TruView glass vials are manufactured and certified to perform better than any commercially available glass autosampler vial."

TruView vials are manufactured under tight controls using a proprietary process that limits the concentration of free ions on the surface of the glass dramatically lowering analyte adsorption.  Normally during the manufacture of glass vials, free ions are deposited on the surface. Problems occur when the ions are freed from the surface and enter the sample raising the pH and exposing ion exchange sites on the glass to sample analytes that can bind to the glass. The longer a vial awaits aspiration and injection of its contents, the greater the analyte adsorption.

Waters TruView LCMS Certified Vials are now available from Waters worldwide.

More information: www.waters.com/vials

About Waters Corporation (www.waters.com)

For more than 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters and TruView are trademarks of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting
2. Waters CE Marks In Vitro Diagnostic MassTrak Immunosuppressants XE Kit
3. Waters Introduces Ostro Sample Preparation Products
4. Waters Expands Xevo MS Instrument Platform With Next-Generation Mass Spectrometers
5. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
6. Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard
7. New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals
8. BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
9. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
10. Cardinal Health Introduces New Latex, Powder-Free, Hydrogel Surgical Gloves
11. Sensitech Inc. Introduces Temperature and Humidity Monitor for Flammable and Hazardous Environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... January 19, 2017 The global  pacemaker market  is expected ... Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled with the ... Pacemaker globally. In addition, technological enhancements in these devices are supporting the expansion ... ... Grand View Research Logo ...
(Date:1/19/2017)...   Synthetic Biologics, Inc. (NYSE MKT: ... to preserve the microbiome to protect and restore ... initiate a Phase 2b/3 adaptive pivotal trial for ... designed to reduce methane production by certain microorganisms ... treat the underlying cause of irritable bowel syndrome ...
(Date:1/18/2017)... DALLAS , Jan. 18, 2017  Aprima ... health records (EHR), practice management (PM) and revenue ... announced the acquisition of a former reseller Healthcare ... part of the agreement, Aprima will assume full ... providers in 125 medical practices across 15 states. ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... “Knowledge is God’s Lighthouse”: a moving and colorful collection of prayers that ... of published author, Gene Gaapf, a retired truck driver, and a long-time writer, whose ... since high school and have many different titles,” Gaapf mentions about his different works. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
(Date:1/19/2017)... ... , ... This month, the CEO and Clinical Director of Sober Living Outpatient, ... in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO Recovery ... Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed kids ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Cosmetic ... of plastic surgery procedures in order to make it easier for their readers to ... of the body they impact as well as the techniques used on those particular ...
(Date:1/19/2017)... ... January 19, 2017 , ... MB Business ... new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, LLC, dba ... to facilitate a recapitalization of MedPro led by Harren Equity Partners. Brightwood ...
Breaking Medicine News(10 mins):